BioForce Nanosciences (BFNH) & The Competition Head to Head Comparison

BioForce Nanosciences (OTCMKTS:BFNHGet Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare BioForce Nanosciences to similar businesses based on the strength of its risk, analyst recommendations, valuation, dividends, institutional ownership, earnings and profitability.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for BioForce Nanosciences and its peers, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioForce Nanosciences 0 0 0 0 N/A
BioForce Nanosciences Competitors 147 959 1633 50 2.57

As a group, “Analytical instruments” companies have a potential upside of 47.35%. Given BioForce Nanosciences’ peers higher probable upside, analysts plainly believe BioForce Nanosciences has less favorable growth aspects than its peers.

Volatility & Risk

BioForce Nanosciences has a beta of -1.49, meaning that its stock price is 249% less volatile than the S&P 500. Comparatively, BioForce Nanosciences’ peers have a beta of 1.21, meaning that their average stock price is 21% more volatile than the S&P 500.

Earnings & Valuation

This table compares BioForce Nanosciences and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
BioForce Nanosciences $20,000.00 -$500,000.00 -205.00
BioForce Nanosciences Competitors $1.16 billion $344.59 million -24.61

BioForce Nanosciences’ peers have higher revenue and earnings than BioForce Nanosciences. BioForce Nanosciences is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares BioForce Nanosciences and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BioForce Nanosciences N/A N/A -2,538.94%
BioForce Nanosciences Competitors -250.85% 6.38% -11.11%

Institutional & Insider Ownership

62.0% of shares of all “Analytical instruments” companies are owned by institutional investors. 39.5% of BioForce Nanosciences shares are owned by company insiders. Comparatively, 13.4% of shares of all “Analytical instruments” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

BioForce Nanosciences peers beat BioForce Nanosciences on 8 of the 10 factors compared.

BioForce Nanosciences Company Profile (Get Rating)

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. The company is based in Virginia Beach, Virginia.

Want More Great Investing Ideas?

Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.